Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, Léon, Jung, Grace, Valore, Erika V, Rivella, Stefano, Nemeth, Elizabeta, Ganz, Tomas·2014·Nature Genetics
DOI 10.1038/ng.2996

Cited by (1,000)

Items 501–600 of 1,000

  1. Polycythaemia vera
    Claire N. Harrison, Tiziano Barbui, Prithviraj Bose, Jean‐Jacques Kiladjian, John O Mascarenhas, Mary Frances McMullin, Ruben A. Mesa, Alessandro Maria Vannucchi · 2025 · Nature Reviews Disease Primers
  2. Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration
    Yu-Jung Tseng, Yuki Kageyama, Rebecca L. Murdaugh, Ayumi Kitano, Jong Hwan Kim, Kevin A. Hoegenauer, Jonathan Tiessen, Mackenzie H. Smith, Hidetaka Uryu, Koichi Takahashi et al. · 2024 · Nature Communications
  3. How I treat iron overload in adult MDS
    Heather A. Leitch, Rena J. Buckstein · 2024 · Blood
  4. The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis
    Shanqi Guo, Xingkang Jiang, Yuanyuan Wang, Liwei Chen, Huzi Li, Xiaojiang Li, Yingjie Jia · 2017 · Cellular Signalling
  5. At the crossroads of oxygen and iron sensing: hepcidin control of HIF-2α
    Frank S. Lee · 2018 · Journal of Clinical Investigation
  6. Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
    Yumei Huang, Rongrong Liu, Xiaoyun Wei, Jiaodi Liu, Lingyuan Pan, Gaohui Yang, Yongrong Lai · 2019 · BioMed Research International
  7. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia
    Rasha Abd El‐Rahman El‐Gamal, Ibrahim Youssef Abdel-Messih, Deena Mohamed Habashy, Shams ElDoha Galal ElDin Zaiema, Shaimaa Abdelmalik Pessar · 2019 · Annals of Hematology
  8. Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis
    Matthew A. Held, Emily Greenfest‐Allen, Edward Jachimowicz, Christian J. Stoeckert, Matthew P. Stokes, Antony W. Wood, Don M. Wojchowski · 2020 · Experimental Hematology
  9. CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts
    Qian Zhao, Chenglin Zhang, Ruo‐Lan Xiang, Li‐Ling Wu, Li Li · 2020 · Cardiovascular Drugs and Therapy
  10. Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia
    Adam N. Goldfarb, Katie C. Freeman, Ranjit Kumar Sahu, Kamaleldin E. Elagib, Maja Holy, Abhinav Arneja, Renata Polanowska‐Grabowska, Alejandro Ariel Gru, Zollie White, Shadi Khalil et al. · 2021 · Nature Communications
  11. Adaptive immunity and vaccination – iron in the spotlight
    Alexandra E. Preston, Hal Drakesmith, Joe N. Frost · 2021 · Immunotherapy Advances
  12. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation
    Soichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, Tatsuki Uchiyama, Chisaki Mizumoto, Toshiyuki Kitano, Tadakazu Kondo, Masakatsu Hishizawa, Naohisa Tomosugi, Akifumi Takaori‐Kondo · 2016 · Cancer Medicine
  13. Low Hepcidin in Type 2 Diabetes Mellitus: Examining the Molecular Links and Their Clinical Implications
    Driton Vela, Ramadan Sopi, Mitko I. Mladenov · 2017 · Canadian Journal of Diabetes
  14. Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia
    L. Quintana‐Castanedo, Rocío Maseda, Isabel Pérez‐Conde, Nora V. Butta, Elena Monzón Manzano, Paula Acuña, María G. Crespo, Antonio Buño Soto, Eva Jiménez, Jaris Valencia et al. · 2025 · Blood Advances
  15. Emerging Pathogenetic Mechanisms and New Drugs for Anemia in Myelofibrosis and Myelodysplastic Syndromes
    Naseema Gangat, Ayalew Tefferi · 2025 · American Journal of Hematology
  16. A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
    Annelies J. van Vuren, Alaa Sharfo, Simon T. Grootendorst, Stephanie van Straaten, Arjen M. Punt, Jesper Petersen, Daniel El Fassi, Wouter W. van Solinge, Marije Bartels, Richard van Wijk et al. · 2021 · HemaSphere
  17. How I treat anemia with red blood cell transfusion and iron
    Jeffrey L. Carson, Gary M. Brittenham · 2022 · Blood
  18. Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass
    Jorge Luis Petro, María Carolina Fragozo-Ramos, Andrés F. Milán, Juan Carlos Aristizábal, Jaime Gallo‐Villegas, Juan Camilo Calderón · 2023 · International Journal of Molecular Sciences
  19. Iron replacement therapy
    Ole Haagen Nielsen, Mehmet Coskun, Günter Weiß · 2016 · Current Opinion in Gastroenterology
  20. Lipidomics reveals perturbations in the liver lipid profile of iron-overloaded mice
    Haoxuan Ding, Qian Zhang, Xiaonan Yu, Lingjun Chen, Zhonghang Wang, Jie Feng · 2021 · Metallomics
  21. Molecular Mechanisms of Iron Metabolism and Overload
    Aditi Tayal, Jasmeen Kaur, Payam Sadeghi, Robert W. Maitta · 2025 · Biomedicines
  22. Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome – Emphasis on optimized dosing schedules and new formulations
    Florian Nolte, Emanuele Angelucci, Massimo Breccia, Norbert Gattermann, Valeria Santini, Norbert Vey, Wolf‐Karsten Hofmann · 2015 · Leukemia Research
  23. The use of hypotransferrinemic mice in studies of iron biology
    Julia T. Bu, Thomas Benedict Bartnikas · 2015 · BioMetals
  24. Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia
    Elliott F. Winton, Vamsi K Kota · 2016 · Future Oncology
  25. Myonectin inhibits the differentiation of osteoblasts and osteoclasts in mouse cells
    Miku Kawaguchi, Naoyuki Kawao, Yoshimasa Takafuji, Masayoshi Ishida, Hiroshi Kaji · 2020 · Heliyon
  26. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant
    Michelle Pirotte, Marianne Fillet, Laurence Seidel, Aurélie Jaspers, Frédéric Baron, Yves P. Beguin · 2021 · American Journal of Hematology
  27. Indirect biomarkers of blood doping: A systematic review
    Bastien Krumm, JONAS J. SAUGY, Francesco Botrè, Francesco Donati, Raphaël Faiss · 2023 · Drug Testing and Analysis
  28. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice
    Wenbin An, Maria Feola, Srinivas Aluri, Marc Ruíz-Martínez, Ashwin Shridharan, Maayan Levy, Eitan Fibach, Xiaofan Zhu, Amit Verma, Yelena Z. Ginzburg · 2023 · eLife
  29. Erythroferrone in focus: emerging perspectives in iron metabolism and hematopathologies
    Sadia Babar, Muhammad Saboor · 2024 · Blood Science
  30. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia
    Khaled M. Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio, Ali T. Taher · 2024 · Expert Review of Hematology
  31. Iron
    Marianne Wessling‐Resnick · 2016 · Elsevier eBooks
  32. Increased Hepcidin Levels During a Period of High Training Load Do Not Alter Iron Status in Male Elite Junior Rowers
    Martina Zügel, Gunnar Treff, Jürgen Michael Steinacker, Benjamin Mayer, Kay Winkert, Uwe Schümann · 2020 · Frontiers in Physiology
  33. New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism
    Gaetano Cairo, Stefania Recalcati, Elena Gammella · 2015 · Hypoxia
  34. Next-Generation Biomarkers for Iron Status
    Hal Drakesmith · 2016 · Nestlé Nutrition Institute Workshop series
  35. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis
    Ilona Rybińska, Gaetano Cairo · 2017 · Vitamins and hormones
  36. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling
    Matthew A. Held, Emily Greenfest‐Allen, Su Su, Christian J. Stoeckert, Matthew P. Stokes, Don M. Wojchowski · 2020 · Cellular Signalling
  37. Tackling the unknowns in understanding and management of hospital acquired anemia
    Eric Bressman, Jeffrey S. Jhang, John H. McClaskey, Yelena Z. Ginzburg · 2021 · Blood Reviews
  38. Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics
    Padmanaban Venkatesan, Joe Varghese, T.S. Arthi, Jithu V. James, Anji Anura, Jasmin Prasad, Molly Jacob · 2021 · Journal of Diabetes and its Complications
  39. Cardiorenal Syndrome in End-Stage Kidney Disease
    Kazuhiko Tsuruya, Masahiro Eriguchi, Shunsuke Yamada, Hideki Hirakata, Takanari Kitazono · 2015 · Blood Purification
  40. Suppression of plasma hepcidin by venesection during steady-state hypoxia
    Nick P. Talbot, Thomas G. Smith, Samira Lakhal‐Littleton, Cafer İkbal Gülsever, Maria C. Rivera, Keith L. Dorrington, David Robert Mole, Peter A. Robbins · 2016 · Blood
  41. Iron Deficiency Anemia
    Na Hee Lee · 2020 · Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology
  42. Assessment of iron deficiency
    Chaim Hershko · 2018 · Haematologica
  43. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents
    Shinjiro Inomata, Akira Anan, Eri Yamauchi, Ryo Yamauchi, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Keiji Yokoyama, Daisuke Morihara, Yasuaki Takeyama et al. · 2019 · Internal Medicine
  44. The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance
    Simon T. Grootendorst, Jonathan R.A. de Wilde, Birgit van Dooijeweert, Annelies J. van Vuren, Wouter W. van Solinge, Roger E. G. Schutgens, Richard van Wijk, Marije Bartels · 2021 · International Journal of Molecular Sciences
  45. Pathophysiology of Iron Homeostasis
    Gary M. Brittenham · 2017 · Elsevier eBooks
  46. Disorders of Iron Homeostasis
    Gary M. Brittenham · 2017 · Elsevier eBooks
  47. Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects
    Olivier Loréal, Thibault Cavey, François Robin, Moussa Kenawi, Pascal Guggenbuhl, Pierre Brissot · 2018 · Pharmaceuticals
  48. Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM.
    Federica Pilo · 2019 · Mediterranean Journal of Hematology and Infectious Diseases
  49. Systemic Iron Metabolism
    Tomas Ganz · 2025 · Advances in experimental medicine and biology
  50. Iron and erythropoiesis: A mutual alliance
    Laura Silvestri, Antonella Nai · 2021 · Seminars in Hematology
  51. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples
    Katherine M. Delaney, Ronnie Guillet, Eva K. Pressman, Tomas Ganz, Elizabeta Nemeth, Kimberly O O'Brien · 2021 · Journal of Nutrition
  52. Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice
    Kornvipa Settakorn, Sarawut Kongkarnka, Anchan Chompupoung, Saovaros Svasti, Suthat Fucharoen, John B. Porter, Somdet Srichairatanakool, Pimpisid Koonyosying · 2022 · Frontiers in Physiology
  53. Activation of Intestinal HIF2α Ameliorates Iron‐Refractory Anemia
    Yingying Yu, Yunxing Su, Sisi Yang, Yutong Liu, Zhiting Lin, Nupur Kanti Das, Qian Wu, Jiahui Zhou, Shumin Sun, Xiaopeng Li et al. · 2024 · Advanced Science
  54. Interaction of Transfusion and Iron Chelation in Thalassemias
    John B. Porter, Maciej Garbowski · 2018 · Hematology/Oncology Clinics of North America
  55. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
    Tewodros Shibabaw, Banchamlak Teferi, Meseret Derbew Molla, Birhanu Ayelign · 2020 · Breast Cancer Targets and Therapy
  56. C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19
    Yaoli Xie, Zhijun Meng, Jia Gao, Caihong Liu, Jing Wang, Rui Guo, Jianli Zhao, Bernard Lopez, Theodore A. Christopher, Daniel Lee et al. · 2021 · Proteomes
  57. Direct modulation of hepatocyte hepcidin signaling by iron
    Linna Yu, Shijin Wang, Cheng Chen, Vanessa Rausch, Omar Elshaarawy, Sebastian Mueller · 2021 · World Journal of Hepatology
  58. Combined treatment of 3-hydroxypyridine-4-one derivatives and green tea extract to induce hepcidin expression in iron-overloaded β-thalassemic mice
    Supranee Upanan, Kanjana Pangjit, Chairat Uthaipibull, Suthat Fucharoen, Andrew Tristan McKie, Somdet Srichairatanakool · 2015 · Asian Pacific Journal of Tropical Biomedicine
  59. Erythropoiesis
    Ajay K. Singh · 2018 · Elsevier eBooks
  60. Iron Metabolism in Chronic Kidney Disease Patients
    Hirokazu Honda, Nozomu Hosaka, Tomas Ganz, Takanori Shibata · 2019 · Contributions to nephrology
  61. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload
    Aaron M. Wortham, Devorah C. Goldman, Juxing Chen, WH Fleming, An‐Sheng Zhang, Caroline A. Enns · 2020 · Journal of Biological Chemistry
  62. Protein Modifications Critical for Myonectin/Erythroferrone Secretion and Oligomer Assembly
    Ashley N. Stewart, Hannah C. Little, David J. Clark, Hui Zhang, Guang William Wong · 2020 · Biochemistry
  63. Peripheral expression of hepcidin gene in Egyptian β-thalassemia major
    Azza Aboul Enein, Amal M. El-Beshlawy, Mona Mohamed Hamdy, Iman Abd El-Mohsen Shaheen, Zainab Ali El-Saadany, Ahmed Samir, Hala Abd El-Samie · 2015 · Gene
  64. Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease
    Yelena Z. Ginzburg · 2023 · Vitamins and hormones
  65. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
    Naglaa Makram Farag, Mahmoud Mohamed Mousa, Eman Elsayed, ahlam ismeil · 2023 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  66. Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency
    Eduard Johannes van Beers, Hanny T. Al-Samkari, Rachael F. Grace, Wilma Barcellini, Andreas Birkedal Glenthøj, Melissa L. DiBacco, Megan Wind‐Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel et al. · 2024 · Blood Advances
  67. The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction
    Taku Nakai, Daisuke Saigusa, Koichiro Kato, Tomoko Fukuuchi, S. Koshiba, Masayuki P. Yamamoto, Norio Suzuki · 2024 · Life Sciences
  68. Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients
    Abhijit V. Kshirsagar, Xiaojuan Li · 2019 · Advances in Chronic Kidney Disease
  69. A role for hepcidin in the anemia caused by Trypanosoma brucei infection
    João Vilares Neves, Ana Cordeiro Gomes, David Mendes Costa, Carolina Barroso, Sophie Vaulont, Anabela Cordeiro‐da‐Silva, Joana Tavares, Pedro Rodrigues · 2020 · Haematologica
  70. Targeted autophagy disruption reveals the central role of macrophage iron metabolism in systemic iron homeostasis
    Meriem Taleb, Isabelle Maillet, Marc Le Bert, Catherine Mura · 2022 · Blood
  71. Pathogenic Mechanisms in Thalassemia II
    Tomas Ganz, Elizabeta Nemeth · 2023 · Hematology/Oncology Clinics of North America
  72. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits
    Lucie Sulovská, Dušan Holub, Zuzana Zidova, Martina Divoká, Marián Hajdúch, Vladimír Mihál, Jana Vrbková, Monika Horváthová, Dagmar Pospı́šilová · 2015 · Biomedical Papers
  73. Effect of procyanidin on dietary iron absorption in hereditary hemochromatosis and in dysmetabolic iron overload syndrome: A crossover double-blind randomized controlled trial
    Hervé Lobbes, Cécile Gladine, Andrzej Mazur, Bruno Pereira, Christian Dualé, Jean‐Michel Cardot, M. Ruivard · 2019 · Clinical Nutrition
  74. Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans
    Shuting Wei, Wei Liu, Yu Qi, Yifan Guo, Shuping Zhang, Li Wang, Taifeng Zhuang, Na Zhang, Sijin Liu · 2020 · British Journal of Haematology
  75. FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy
    Erica Mina, Elisabeth Wyart, Roberta Sartori, Elia Angelino, Ivan Zaggia, Valentina Rausch, Mara Maldotti, Alessia Pagani, Myriam Y. Hsu, Alberto Friziero et al. · 2023 · Cell Reports Medicine
  76. Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias – pilot study protocol
    Andreas Birkedal Glenthøj, Eduard Johannes van Beers, Richard van Wijk, Minke A.E. Rab, Evelyn Groot, Niels Grove Vejlstrup, Nina Toft, Selma Kofoed Bendtsen, Jesper Petersen, Jens Helby et al. · 2024 · BMJ Open
  77. Vamifeport: Monography of the First Oral Ferroportin Inhibitor
    Federica Pilo, Emanuele Angelucci · 2024 · Journal of Clinical Medicine
  78. To induce or not to induce: the fight over hepcidin regulation
    Veena Sangkhae, Elizabeta Nemeth · 2019 · Haematologica
  79. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias
    Zeynep Öztürk, Saadet Gümüşlü, Koray Yalçın, Alphan Küpesiz · 2020 · Journal of Pediatric Hematology/Oncology
  80. Advances in understanding the crosstalk between mother and fetus on iron utilization
    Samira Lakhal‐Littleton · 2021 · Seminars in Hematology
  81. The role of iron in obesity and diabetes
    Yasumasa Ikeda, Masafumi Funamoto, Koichiro Tsuchiya · 2022 · The Journal of Medical Investigation
  82. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion‐independent a murine model of transfusion‐dependent β‐thalassemia
    Simona Maria Di Modica, Emanuele Tanzi, Violante Olivari, Maria Rosa Lidonnici, Mariateresa Pettinato, Alessia Pagani, Francesca Tiboni, Valeria Furiosi, Laura Silvestri, Giuliana Ferrari et al. · 2022 · American Journal of Hematology
  83. Governing roles for Trib3 pseudokinase during stress erythropoiesis
    Arvind Dev, Ruth Asch, Edward Jachimowicz, Nicole Rainville, Ashley Johnson, Emily Greenfest‐Allen, Don M. Wojchowski · 2017 · Experimental Hematology
  84. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells
    Shogo Miura, Masayoshi Kobune, Hiroto Horiguchi, Shohei Kikuchi, Satoshi Iyama, Kazuyuki Murase, Akari Goto, Hiroshi Ikeda, Kohichi Takada, Koji Miyanishi et al. · 2019 · Blood Cells Molecules and Diseases
  85. Role of the kidneys in the redistribution of heme-derived iron during neonatal hemolysis in mice
    Aleksandra Bednarz, Paweł Lipiński, Rafał R. Starzyński, Mateusz Tomczyk, Witold Norbert Nowak, Olga Mucha, Mateusz Ogórek, Olga Pierzchała, Aneta Jończy, Robert Staroń et al. · 2019 · Scientific Reports
  86. Circulating Myonectin and Irisin Levels in Gestational Diabetes Mellitus – A Case-control Study
    Taylan Onat, Nihal İnandıklıoğlu · 2021 · Zeitschrift für Geburtshilfe und Neonatologie
  87. Iron homeostasis governs erythroid phenotype in Polycythemia Vera
    Cavan Bennett, Victoria E. Jackson, Anne Pettikiriarachchi, Thomas Hayman, Ute Schaeper, Gemma Moir-Meyer, Katherine Fielding, Ricardo Ataíde, Danielle B. Clucas, Andrew Baldi et al. · 2023 · Blood
  88. Experimental and investigational therapies for chemotherapy-induced anemia
    Ugo Testa, Germana Castelli, Pelosi Elvira · 2015 · Expert Opinion on Investigational Drugs
  89. Dietary supplementation with ipriflavone decreases hepatic iron stores in wild type mice
    Bonnie Patchen, Tiago Koppe, Aaron Cheng, Young Ah Seo, Marianne Wessling‐Resnick, Paula Goodman Fraenkel · 2016 · Blood Cells Molecules and Diseases
  90. Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis
    Emanuela Tolosano · 2015 · Haematologica
  91. Erythroferrone in iron regulation and beyond
    Jodie L. Babitt · 2022 · Blood
  92. Current Landscape of Hepcidin Therapeutics
    Antonella Nai, Laura Silvestri, Michela Asperti, Francesca Vinchi · 2025 · Advances in experimental medicine and biology
  93. Anemia of chronic diseases: current state of the problem and perspectives
    Olga Iu. Mironova, Alexandr S. Panferov · 2023 · Terapevticheskii arkhiv
  94. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats
    Fang Cui, Jie Yun Sun, Haichao Mi, Bo Li, Longmei Tang, Ruotong Wang, Yutao Du, Bingyan Guo, Yongjun Li, Min Shi · 2023 · Journal of Trace Elements in Medicine and Biology
  95. Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia
    Xiuqi Li, Larisa Lozovatsky, Steven M. Tommasini, Jackie A. Fretz, Karin E. Finberg · 2023 · Blood Advances
  96. EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
    Nienke Schotten, Coby M. Laarakkers, Rian Roelofs, Raffaella Origa, Marian G.J. van Kraaij, Dorine W. Swinkels · 2016 · American Journal of Hematology
  97. Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats
    Iuliia Gurieva, Jana Frýdlová, Zuzana Rychtarčíková, Martin Vokurka, Jaroslav Truksa, Jan Krijt · 2017 · Blood Cells Molecules and Diseases
  98. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent
    Maja Tomczyk, Jakub Antoni Kortas, Damian Józef Flis, Barbara Kaczorowska-Hać, Agata Grzybkowska, Andżelika Borkowska, Ewa Lewicka, Alicja Dąbrowska-Kugacka, Jędrzej Antosiewicz · 2020 · International Journal of Environmental Research and Public Health
  99. Iron Transporter Protein Expressions in Children with Celiac Disease
    Marleena Repo, Markus Hannula, Juha Taavela, Jari Hyttinen, Jorma J Isola, Pauliina Hiltunen, Alina Popp, Katri Kaukinen, Kalle Kurppa, Katri Lindfors · 2021 · Nutrients
  100. Methodological Considerations for Investigating Iron Status and Regulation in Exercise and Sport Science Studies
    Alannah K. A. McKay, Marc Sim, Diego Moretti, Rebecca C. Hall, Trent Stellingwerff, Richard J. Burden, Peter Peeling · 2022 · International Journal of Sport Nutrition and Exercise Metabolism